Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ruud Dings

Concepts (309)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
24
2022
203
4.200
 Why?
Neovascularization, Pathologic
17
2022
168
2.550
 Why?
Proteins
16
2010
376
2.500
 Why?
Calixarenes
7
2017
9
2.100
 Why?
Melanoma, Experimental
6
2021
49
1.950
 Why?
Galectin 1
7
2017
21
1.710
 Why?
Antineoplastic Agents
12
2024
1300
1.540
 Why?
Peptides
19
2017
276
1.410
 Why?
Mice
46
2024
6413
1.290
 Why?
Neoplasms
13
2020
1315
1.140
 Why?
Endothelial Cells
10
2022
294
1.100
 Why?
Animals
51
2024
14385
1.030
 Why?
Lung Neoplasms
4
2024
642
0.930
 Why?
Gold
7
2023
164
0.920
 Why?
Ovarian Neoplasms
8
2008
472
0.910
 Why?
Oxygen
6
2020
361
0.890
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
164
0.820
 Why?
Cell Line, Tumor
17
2024
1550
0.790
 Why?
Proto-Oncogene Proteins c-met
1
2021
21
0.790
 Why?
Carcinoma, Squamous Cell
4
2019
384
0.780
 Why?
Mammary Neoplasms, Experimental
6
2015
135
0.760
 Why?
Peptide Fragments
5
2013
242
0.760
 Why?
Radiation-Sensitizing Agents
4
2023
55
0.750
 Why?
Carcinoma, Lewis Lung
1
2019
11
0.720
 Why?
Head and Neck Neoplasms
3
2019
335
0.710
 Why?
Molecular Targeted Therapy
2
2018
128
0.700
 Why?
Protein Kinase Inhibitors
1
2021
216
0.690
 Why?
Preservation, Biological
1
2018
10
0.680
 Why?
Lymphocytes, Tumor-Infiltrating
1
2019
74
0.680
 Why?
CD8-Positive T-Lymphocytes
1
2019
116
0.670
 Why?
Radiation Tolerance
5
2020
86
0.670
 Why?
Galectins
1
2018
5
0.650
 Why?
Anti-Bacterial Agents
4
2019
820
0.650
 Why?
Metal Nanoparticles
4
2023
96
0.600
 Why?
Hyperthermia, Induced
3
2019
107
0.600
 Why?
Mice, Nude
12
2019
283
0.580
 Why?
Bacteria
1
2018
258
0.570
 Why?
Radiotherapy
5
2021
138
0.570
 Why?
Xenograft Model Antitumor Assays
10
2020
219
0.540
 Why?
Pseudomonas aeruginosa
2
2013
86
0.520
 Why?
Benzofurans
2
2012
18
0.460
 Why?
Combined Modality Therapy
11
2020
692
0.460
 Why?
Cytotoxins
1
2013
17
0.460
 Why?
Pseudomonas Infections
1
2013
54
0.440
 Why?
Drug Design
4
2014
133
0.440
 Why?
Carbohydrate Metabolism
1
2012
31
0.430
 Why?
Nanostructures
3
2023
53
0.420
 Why?
Bacteremia
1
2013
101
0.410
 Why?
Sesquiterpenes
3
2010
91
0.400
 Why?
Angiostatic Proteins
1
2011
1
0.400
 Why?
Cell Proliferation
9
2017
1096
0.390
 Why?
Immunity, Cellular
1
2011
80
0.380
 Why?
Humans
41
2024
54246
0.380
 Why?
Endothelium, Vascular
7
2010
288
0.380
 Why?
Molecular Mimicry
2
2007
64
0.370
 Why?
Dendritic Cells
3
2021
142
0.370
 Why?
Endothelium
4
2022
45
0.370
 Why?
Neoplasms, Experimental
3
2020
115
0.370
 Why?
Immunotherapy, Adoptive
1
2011
134
0.360
 Why?
Carboplatin
3
2024
62
0.360
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1056
0.350
 Why?
Tumor Necrosis Factor-alpha
4
2019
434
0.340
 Why?
Intercellular Adhesion Molecule-1
5
2022
75
0.330
 Why?
Vascular Endothelial Growth Factor A
7
2022
230
0.330
 Why?
Cells, Cultured
8
2013
1737
0.330
 Why?
Structure-Activity Relationship
6
2012
423
0.330
 Why?
Polyethylene Glycols
3
2021
106
0.320
 Why?
T-Lymphocytes
1
2011
373
0.320
 Why?
Mice, Inbred C57BL
8
2021
1999
0.320
 Why?
Cell Survival
7
2021
657
0.320
 Why?
Phototherapy
2
2019
53
0.320
 Why?
Tumor Cells, Cultured
6
2019
477
0.310
 Why?
Drug Resistance, Neoplasm
2
2024
309
0.300
 Why?
Amino Acid Sequence
5
2012
767
0.300
 Why?
Female
24
2020
28418
0.290
 Why?
Magnetic Resonance Spectroscopy
5
2012
253
0.290
 Why?
Blood Vessels
4
2015
78
0.280
 Why?
Antibodies, Monoclonal
2
2007
562
0.270
 Why?
Molecular Sequence Data
5
2012
980
0.260
 Why?
Disease Models, Animal
7
2020
1639
0.260
 Why?
Nanoparticles
2
2017
173
0.250
 Why?
Human Umbilical Vein Endothelial Cells
3
2014
95
0.250
 Why?
Buthionine Sulfoximine
1
2024
17
0.240
 Why?
Nanotubes
2
2021
38
0.240
 Why?
Cell Division
6
2010
330
0.230
 Why?
Alanine
3
2012
44
0.210
 Why?
Flow Cytometry
2
2017
546
0.210
 Why?
Oxidation-Reduction
2
2020
382
0.210
 Why?
Carcinoma, Renal Cell
1
2022
120
0.200
 Why?
Protein Binding
3
2012
736
0.200
 Why?
Cisplatin
1
2024
352
0.200
 Why?
Optical Imaging
2
2020
30
0.200
 Why?
Binding Sites
2
2012
440
0.200
 Why?
Polyurethanes
1
2021
9
0.200
 Why?
Silver
2
2021
54
0.200
 Why?
Radiation
1
2020
17
0.190
 Why?
Kidney Neoplasms
1
2022
196
0.190
 Why?
Forkhead Transcription Factors
1
2021
118
0.190
 Why?
Materials Testing
1
2021
62
0.190
 Why?
Spectrum Analysis
1
2020
79
0.190
 Why?
Biocompatible Materials
1
2021
65
0.190
 Why?
Mice, Inbred BALB C
5
2020
368
0.180
 Why?
Neoplasm Transplantation
5
2007
94
0.180
 Why?
Mice, Knockout
3
2012
926
0.180
 Why?
CD4-Positive T-Lymphocytes
1
2021
180
0.180
 Why?
Disease Progression
3
2019
913
0.180
 Why?
Models, Molecular
3
2012
423
0.180
 Why?
Oxygen Consumption
1
2020
223
0.180
 Why?
Benzeneacetamides
1
2019
9
0.170
 Why?
Glutaminase
1
2019
14
0.170
 Why?
Thiadiazoles
1
2019
15
0.170
 Why?
Spectrum Analysis, Raman
1
2019
68
0.170
 Why?
Specimen Handling
1
2018
62
0.170
 Why?
Biological Assay
1
2018
55
0.160
 Why?
Immunotherapy
1
2020
263
0.160
 Why?
Feces
1
2018
135
0.160
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
60
0.160
 Why?
Indazoles
1
2018
55
0.160
 Why?
Temperature
1
2018
177
0.160
 Why?
Carbohydrates
1
2018
64
0.160
 Why?
Cell Hypoxia
4
2015
87
0.160
 Why?
Time Factors
6
2017
3212
0.150
 Why?
Tumor Microenvironment
1
2019
209
0.150
 Why?
Histocompatibility Antigens Class II
1
2017
43
0.150
 Why?
Drug Delivery Systems
1
2019
151
0.150
 Why?
Apoptosis
5
2023
1300
0.150
 Why?
Lipopolysaccharides
2
2008
199
0.140
 Why?
Drug Therapy, Combination
1
2018
426
0.140
 Why?
Neoplastic Cells, Circulating
1
2017
93
0.140
 Why?
Epithelial Cells
1
2018
255
0.140
 Why?
Male
9
2019
27312
0.140
 Why?
Umbilical Veins
4
2010
23
0.140
 Why?
Enzyme Inhibitors
1
2018
446
0.130
 Why?
Leukocytes
3
2006
85
0.130
 Why?
Molecular Imaging
1
2015
60
0.130
 Why?
Azides
1
2014
9
0.130
 Why?
Fluorine Radioisotopes
1
2014
25
0.130
 Why?
Cell Line
3
2017
1153
0.130
 Why?
Tumor Burden
2
2013
142
0.130
 Why?
Cell Transformation, Neoplastic
2
2007
200
0.120
 Why?
Interleukin-2
2
2021
75
0.120
 Why?
Immunohistochemistry
5
2020
1089
0.120
 Why?
Drug Synergism
2
2005
171
0.120
 Why?
Cell Adhesion
3
2006
171
0.120
 Why?
Piperacillin
1
2013
25
0.110
 Why?
Peptidomimetics
1
2012
3
0.110
 Why?
Lactose
1
2012
10
0.110
 Why?
Penicillanic Acid
1
2013
23
0.110
 Why?
Agglutination Tests
1
2012
5
0.110
 Why?
Allosteric Regulation
1
2012
14
0.110
 Why?
Inflammation Mediators
1
2013
128
0.110
 Why?
Cell Cycle
1
2013
275
0.100
 Why?
Antimicrobial Cationic Peptides
2
2008
31
0.100
 Why?
Partial Pressure
1
2011
17
0.100
 Why?
Metformin
1
2012
66
0.100
 Why?
Neoplastic Stem Cells
1
2012
103
0.100
 Why?
Up-Regulation
2
2011
508
0.100
 Why?
Adjuvants, Immunologic
1
2011
61
0.100
 Why?
Chemotherapy, Adjuvant
1
2011
119
0.100
 Why?
Fibroblasts
1
2013
386
0.090
 Why?
Spiro Compounds
1
2010
8
0.090
 Why?
Cytokines
1
2013
676
0.090
 Why?
Lignans
1
2008
5
0.080
 Why?
Salmonella typhimurium
1
2008
54
0.080
 Why?
Klebsiella pneumoniae
1
2008
23
0.080
 Why?
Furans
1
2008
27
0.080
 Why?
Amino Acid Substitution
1
2008
105
0.080
 Why?
Cell Movement
3
2006
271
0.080
 Why?
Surface Properties
1
2007
79
0.080
 Why?
Angiostatins
2
2006
2
0.080
 Why?
Vascular Neoplasms
1
2007
20
0.070
 Why?
Endotoxins
1
2006
37
0.070
 Why?
Concept Formation
1
2006
11
0.070
 Why?
Gram-Negative Bacteria
1
2006
37
0.070
 Why?
Protein Structure, Secondary
2
2003
99
0.070
 Why?
Escherichia coli
1
2008
250
0.070
 Why?
Interleukin-8
1
2006
97
0.070
 Why?
Genes, Synthetic
1
2005
1
0.070
 Why?
Protein Engineering
1
2005
21
0.070
 Why?
Cloning, Molecular
1
2005
198
0.070
 Why?
Antibodies, Monoclonal, Humanized
1
2007
240
0.070
 Why?
Angiogenic Proteins
1
2004
7
0.060
 Why?
Feasibility Studies
1
2006
398
0.060
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
150
0.060
 Why?
Dietary Supplements
1
2008
449
0.060
 Why?
Diphtheria Toxin
1
2004
4
0.060
 Why?
Colonic Neoplasms
1
2006
164
0.060
 Why?
Mammary Neoplasms, Animal
1
2004
38
0.060
 Why?
Histones
1
2006
335
0.060
 Why?
Osmosis
1
2003
7
0.060
 Why?
Infusion Pumps
1
2003
13
0.060
 Why?
Plasminogen
1
2003
2
0.060
 Why?
Circular Dichroism
1
2003
39
0.060
 Why?
Serum Albumin
1
2003
62
0.060
 Why?
Dose-Response Relationship, Drug
2
2004
1476
0.050
 Why?
Extracellular Matrix
1
2003
111
0.050
 Why?
Immune Tolerance
1
2022
104
0.050
 Why?
Endostatins
3
2007
4
0.050
 Why?
Gene Expression Regulation, Neoplastic
4
2008
866
0.050
 Why?
Neoplasm Invasiveness
1
2022
295
0.050
 Why?
Immunity
1
2021
36
0.050
 Why?
Immune System
1
2021
49
0.050
 Why?
Ethers
1
2021
6
0.050
 Why?
Regenerative Medicine
1
2021
9
0.050
 Why?
Tissue Scaffolds
1
2021
27
0.050
 Why?
Melanoma
1
2004
313
0.050
 Why?
Angiogenesis Inducing Agents
1
2000
8
0.050
 Why?
Tissue Engineering
1
2021
61
0.050
 Why?
Dose-Response Relationship, Radiation
1
2020
204
0.050
 Why?
Mice, Inbred C3H
2
2012
82
0.050
 Why?
Bone Marrow Cells
1
2021
233
0.050
 Why?
Adenocarcinoma
1
2004
428
0.040
 Why?
Gene Expression Profiling
1
2004
1138
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
5
0.040
 Why?
Skin Neoplasms
1
2004
532
0.040
 Why?
NAD
1
2018
46
0.040
 Why?
Inflammation
1
2022
674
0.040
 Why?
Microcirculation
2
2010
89
0.040
 Why?
Glutamine
1
2019
168
0.040
 Why?
Guidelines as Topic
1
2018
125
0.040
 Why?
Phagocytosis
1
2017
51
0.040
 Why?
Glutathione
1
2019
330
0.040
 Why?
Microscopy, Fluorescence
1
2018
198
0.040
 Why?
Glycolysis
1
2017
73
0.040
 Why?
Transplantation, Heterologous
2
2008
77
0.040
 Why?
Clonal Anergy
2
2006
14
0.040
 Why?
Nitroimidazoles
1
2015
17
0.030
 Why?
Extracellular Fluid
1
2015
19
0.030
 Why?
Microbubbles
1
2015
34
0.030
 Why?
Stromal Cells
1
2015
79
0.030
 Why?
Pressure
1
2015
120
0.030
 Why?
Cell Count
1
2015
181
0.030
 Why?
Radiochemistry
1
2014
1
0.030
 Why?
Click Chemistry
1
2014
1
0.030
 Why?
Cycloaddition Reaction
1
2014
1
0.030
 Why?
Down-Regulation
2
2006
388
0.030
 Why?
Drug Evaluation, Preclinical
1
2015
158
0.030
 Why?
Paclitaxel
2
2006
103
0.030
 Why?
Random Allocation
1
2015
312
0.030
 Why?
Radiotherapy Dosage
1
2015
243
0.030
 Why?
Imaging, Three-Dimensional
1
2015
171
0.030
 Why?
Cell Differentiation
1
2017
720
0.030
 Why?
Recombinant Proteins
2
2006
569
0.030
 Why?
Contrast Media
1
2015
221
0.030
 Why?
Molecular Structure
1
2014
319
0.030
 Why?
Ultrasonography
1
2015
480
0.030
 Why?
Chromatography, High Pressure Liquid
1
2014
377
0.030
 Why?
Adenylate Kinase
1
2012
10
0.030
 Why?
Ribosomal Protein S6 Kinases
1
2012
10
0.030
 Why?
TOR Serine-Threonine Kinases
1
2012
85
0.030
 Why?
Radiometry
1
2012
124
0.030
 Why?
Rats
2
2008
3415
0.020
 Why?
4-Butyrolactone
1
2008
6
0.020
 Why?
Butylene Glycols
1
2008
13
0.020
 Why?
Phytoestrogens
1
2008
20
0.020
 Why?
Receptors, Progesterone
1
2008
57
0.020
 Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
54
0.020
 Why?
Ovariectomy
1
2008
125
0.020
 Why?
Estrogen Receptor beta
1
2008
56
0.020
 Why?
Estrogen Receptor alpha
1
2008
95
0.020
 Why?
Cell Growth Processes
1
2007
24
0.020
 Why?
Horseshoe Crabs
1
2006
3
0.020
 Why?
Blood Bactericidal Activity
1
2006
6
0.020
 Why?
Lipid A
1
2006
9
0.020
 Why?
Polymyxin B
1
2006
5
0.020
 Why?
Neutralization Tests
1
2006
33
0.020
 Why?
Cytidine
1
2006
5
0.020
 Why?
Carcinogens
1
2008
231
0.020
 Why?
Endotoxemia
1
2006
31
0.020
 Why?
DNA Modification Methylases
1
2006
32
0.020
 Why?
Pyrroles
1
2007
78
0.020
 Why?
Acetylation
1
2006
99
0.020
 Why?
Methylation
1
2006
130
0.020
 Why?
Chick Embryo
1
2006
79
0.020
 Why?
Vimentin
1
2006
33
0.020
 Why?
Nucleic Acid Hybridization
1
2006
54
0.020
 Why?
Cyclohexanes
1
2006
2
0.020
 Why?
Blood Proteins
1
2006
100
0.020
 Why?
Zebrafish
1
2006
57
0.020
 Why?
Gene Silencing
1
2006
129
0.020
 Why?
Histone Deacetylases
1
2006
47
0.020
 Why?
Histone Deacetylase Inhibitors
1
2006
56
0.020
 Why?
Transfection
1
2007
399
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2006
41
0.020
 Why?
Pichia
1
2005
5
0.020
 Why?
Gene Transfer Techniques
1
2005
41
0.020
 Why?
Cyclophosphamide
1
2006
172
0.020
 Why?
Neovascularization, Physiologic
1
2005
72
0.020
 Why?
Sequence Homology, Nucleic Acid
1
2004
59
0.020
 Why?
Indoles
1
2007
289
0.020
 Why?
Membrane Proteins
1
2006
389
0.020
 Why?
Necrosis
1
2004
208
0.010
 Why?
Antibodies
1
2004
178
0.010
 Why?
In Situ Nick-End Labeling
1
2003
64
0.010
 Why?
Treatment Outcome
1
2014
5604
0.010
 Why?
Sequence Homology, Amino Acid
1
2003
180
0.010
 Why?
Skin
1
2007
469
0.010
 Why?
Base Sequence
1
2004
719
0.010
 Why?
Epigenesis, Genetic
1
2006
399
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
673
0.010
 Why?
Mice, Transgenic
1
2004
656
0.010
 Why?
RNA, Messenger
1
2004
1202
0.010
 Why?
Endothelial Growth Factors
1
2000
8
0.010
 Why?
Vascular Endothelial Growth Factors
1
2000
16
0.010
 Why?
Fibroblast Growth Factor 2
1
2000
33
0.010
 Why?
Lymphokines
1
2000
20
0.010
 Why?
Scrotum
1
2000
34
0.010
 Why?
Interleukin-1
1
2000
107
0.010
 Why?
Breast Neoplasms
1
2004
1248
0.010
 Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (309) concept(s)
_
Co-Authors Expand Description
See all (18) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department